N | % | |
---|---|---|
Hypertension | 50 | 30.5 |
Diabetes | 42 | 25.6 |
Dyslipidemia | 11 | 6.7 |
Cardiopathy | 9 | 5.5 |
Osteoporosis | 24 | 14.7 |
Arthrosis | 40 | 24.4 |
Renal insufficiency | 12 | 7.3 |
CCI ≥ 2 | 23 | 14.2 |
CCI ≥ 3 | 11 | 6.8 |
Fracture in the previous year | 8 | 4.9 |
Fall in the previous year | 54 | 32.9 |
Complication | ||
-Minor | 42 | 83.7 |
-Major | 7 | 14.3 |
Medications/day | ||
-0 | 28 | 18.9 |
- < 3 | 81 | 54.7 |
- ≥ 3 | 39 | 26.4 |
Performance status | ||
- < 2 | 87 | 53.7 |
- ≥ 2 | 75 | 46.3 |
Pain | ||
-Median | 3.21 [0;5] | |
-Pain free | 56 | 35.4 |
-Mild | 47 | 29.7 |
-Moderate | 40 | 25.3 |
-Severe | 15 | 9.5 |
Localization | ||
-Breast | 38 | 23.2 |
-Colorectal | 26 | 15.9 |
-Lung | 23 | 14 |
-Stomach | 13 | 7.9 |
-Prostate | 13 | 7.9 |
-Ovary | 10 | 6.1 |
-Bladder | 9 | 5.5 |
-Other | 32 | 19.5 |
Stage | ||
-Localized | 41 | 25.2 |
-Locally advanced | 22 | 13.5 |
-Metastatic | 72 | 44.2 |
-Recurrence | 28 | 17.1 |
Status | ||
-First consultation | 10 | 6.1 |
-Workup | 13 | 8 |
-Receiving treatment | 117 | 71.8 |
-Follow up | 23 | 14.1 |
Chemotherapy | 140 | 88.6 |
Radiotherapy | 14 | 8.9 |
RCC | 5 | 3.2 |
Hormonal therapy | 10 | 6.3 |
Best supportive care | 4 | 2.5 |
Refusal of intraveinous treatment | 5 | 3 |
Type of treatement | ||
-Standard | 130 | 80.7 |
-Adapted | 31 | 19.2 |
Systematic GCSF | 5 | 3.1 |
Strategy | ||
-Curative | 57 | 34.8 |
-Palliative | 107 | 65.2 |